JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263081

Human AGA knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

AGA KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.

View Alternative Names

AGU, ASPG_HUMAN, ASRG, Aspartylglucosaminidase, Aspartylglucosylamine deaspartylase, Aspartylglycosaminuria, GA, Glycosylasparaginase, Glycosylasparaginase beta chain, N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase

1 Images
Sanger Sequencing - Human AGA knockout HEK-293T cell lysate (AB263081)
  • Sanger seq

Unknown

Sanger Sequencing - Human AGA knockout HEK-293T cell lysate (AB263081)

Homozygous : Insertion of the selection cassette in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263081-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human AGA knockout HEK293T cell lysate", "number":"AB263081-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263081-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
AGA
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The AGA protein also known as Aspartylglucosaminidase has an important role in catalyzing the hydrolysis of glycosylasparagine to glucosamine and aspartic acid. This activity occurs predominantly in the lysosomes. The AGA gene encodes this enzyme which has a molecular mass of approximately 35 kDa. It is expressed in a variety of tissues including the liver and kidney where it contributes significantly to protein degradation.
Biological function summary

Enzymes like AGA help in glycoprotein catabolism which is an essential process for cellular maintenance and function. AGA functions as a homodimer and is an integral part of the lysosomal enzyme complex. This complex ensures proper degradation of N-linked oligosaccharides from glycoproteins following cellular internalization. Disruption in AGA's function results in accumulation of undigested glycoproteins which may affect normal cellular processes.

Pathways

AGA's activity ties into the lysosomal degradation pathway significantly influencing the catabolic reduction of glycoproteins. It is closely related to other lysosomal enzymes such as cathepsins. AGA’s regulation is linked to cellular recycling and energy balance pathways transitioning the breakdown products of glycoproteins into reusable components for other metabolic processes.

AGA is closely related to the condition known as Aspartylglucosaminuria. This rare inherited metabolic disorder results in the accumulation of glycoasparagines due to AGA deficiency leading to various symptoms including intellectual disability and skeletal abnormalities. In this disorder AGA malfunctions can also influence the activity of other lysosomal enzymes exacerbating the cellular effects of the accumulated substrates.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com